Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis

Ewout J N Groen | Machiel J Zwarts | Fernando Rivadeneira | Sven Cichon | Karol Estrada | Albert Hofman | Stefan Schreiber | Eric Strengman | Pierandrea Muglia | Vincent Meininger | Shaun Purcell | Robin Lemmens | Wim Robberecht | Ammar Al-Chalabi | Albert C Ludolph | Markus M Nöthen | Agnieszka Slowik | Orla Hardiman | Ewout J. N. Groen | Peter M Andersen | Barbara Tomik | Caroline Dahlberg | Jonathan D Glass | Marianne de Visser | A. Hofman | A. Uitterlinden | D. Rujescu | S. Cichon | P. Muglia | I. Giegling | L. Kiemeney | R. Ophoff | M. Nöthen | Robert H. Brown | S. Purcell | F. Rivadeneira | H. Wichmann | S. Schreiber | M. Zwarts | A. Al-Chalabi | C. Shaw | P. Andersen | A. Birve | H. Blauw | S. Cronin | J. Glass | O. Hardiman | J. Landers | R. McLaughlin | V. Meininger | J. Melki | W. Robberecht | C. Saris | J. Veldink | E. Strengman | K. Estrada | P. Leigh | H. J. Schelhaas | S. Vermeulen | A. Ludolph | L. Berg | A. Słowik | M. V. Es | J. Wokke | C. Dahlberg | R. Pasterkamp | T. Meyer | B. Tomik | K. Fumoto | R. Lemmens | M. Huisman | Lambertus A Kiemeney | Michael A van Es | Roel A Ophoff | Russell L McLaughlin | Christopher E Shaw | Andre G Uitterlinden | H-Erich Wichmann | Ina Giegling | P Nigel Leigh | Dan Rujescu | S. Waibel | Simon Cronin | Judith Melki | Jan H Veldink | M. Visser | John H J Wokke | Robert H Brown | P. V. Vught | Helenius J Schelhaas | A. Kooi | P. V. Doormaal | C. Hendrich | Leonard H van den Berg | Hylke M Blauw | Anna Birve | Thomas Meyer | John E Landers | Katsumi Fumoto | Stefan Waibel | Christiaan G J Saris | Paul W J van Vught | Mark H B Huisman | Anneke J van der Kooi | Perry T C van Doormaal | Corinna Hendrich | Sita H H M Vermeulen | R Jeroen Pasterkamp | Robert H. Brown | S. Schreiber | L. H. Berg | R. J. Pasterkamp | A. Uitterlinden | M. A. Es | A. Hofman | Robin Lemmens | C. Shaw | R. Mclaughlin

[1]  R. D. de Haan,et al.  The cognitive profile of amyotrophic lateral sclerosis: A meta-analysis , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[2]  Claire L. Simpson,et al.  Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis , 2009, Proceedings of the National Academy of Sciences.

[3]  Sonja W. Scholz,et al.  A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. , 2009, Human molecular genetics.

[4]  David B. Goldstein,et al.  A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia , 2009, PLoS genetics.

[5]  Monique M. B. Breteler,et al.  The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.

[6]  Andrew D. Johnson,et al.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..

[7]  Tony Fletcher,et al.  Sequence variant on 8q24 confers susceptibility to urinary bladder cancer , 2008, Nature Genetics.

[8]  Manuel A. R. Ferreira,et al.  Practical aspects of imputation-driven meta-analysis of genome-wide association studies. , 2008, Human molecular genetics.

[9]  Thomas W. Mühleisen,et al.  Large recurrent microdeletions associated with schizophrenia , 2008, Nature.

[10]  M. Daly,et al.  Estimation of the multiple testing burden for genomewide association studies of nearly all common variants , 2008, Genetic epidemiology.

[11]  Ann B. Lee,et al.  On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants. , 2008, American journal of human genetics.

[12]  F. Schmidt.  Meta-Analysis , 2008 .

[13]  Orla Hardiman,et al.  A genome-wide association study of sporadic ALS in a homogenous Irish population. , 2007, Human molecular genetics.

[14]  Frank Baas,et al.  Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis , 2008, Nature Genetics.

[15]  A. Hofman,et al.  The Rotterdam Study: objectives and design update , 2007, European Journal of Epidemiology.

[16]  R. Ophoff,et al.  ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study , 2007, The Lancet Neurology.

[17]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[18]  Kuixing Zhang,et al.  Whole-genome analysis of sporadic amyotrophic lateral sclerosis. , 2007, The New England journal of medicine.

[19]  Sonja W. Scholz,et al.  Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data , 2007, The Lancet Neurology.

[20]  V. Meininger,et al.  Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p. , 2007, Archives of neurology.

[21]  Sonja W. Scholz,et al.  Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data , 2006, The Lancet Neurology.

[22]  F. Baas,et al.  Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. , 2006, Brain : a journal of neurology.

[23]  H. Horvitz,et al.  A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia , 2006, Neurology.

[24]  Michael Krawczak,et al.  PopGen: Population-Based Recruitment of Patients and Controls for the Analysis of Complex Genotype-Phenotype Relationships , 2006, Public Health Genomics.

[25]  C. Gieger,et al.  KORA-gen - Resource for Population Genetics, Controls and a Broad Spectrum of Disease Phenotypes , 2005 .

[26]  F. Varoqueaux,et al.  Aberrant Morphology and Residual Transmitter Release at the Munc13-Deficient Mouse Neuromuscular Synapse , 2005, Molecular and Cellular Biology.

[27]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[28]  Toshihiro Tanaka.  The International HapMap Project , 2003, Nature.

[29]  R. Miller,et al.  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[30]  R. Miller,et al.  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[31]  D. Grönemeyer,et al.  Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. , 2002, American heart journal.

[32]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[33]  Thomas C. Südhof,et al.  Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles , 1999, Nature.

[34]  C. Hawkes,et al.  British motor neuron disease twin study. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[35]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[36]  Mulder Dw.  Clinical limits of amyotrophic lateral sclerosis. , 1982 .